Scynexis (SCYX) EBIT Margin Growth (5y) (2018 - 2024)
Scynexis (SCYX) EBIT Margin Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 927,345.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 971,393.00 |
| Sep 30, 2022 | 859,824.00 |
| Jun 30, 2022 | 889,598.00 |
| Mar 31, 2022 | 658,029.00 |
| Dec 31, 2021 | 492,824.00 |
| Sep 30, 2021 | 671,049.00 |
| Mar 31, 2021 | 1.13 Mn |
| Jun 30, 2019 | -1.35 Mn |
| Mar 31, 2019 | -1.85 Mn |
| Dec 31, 2018 | -1.38 Mn |
| Sep 30, 2018 | -976,093.00 |
| Jun 30, 2018 | -1.19 Mn |
| Mar 31, 2018 | -1.13 Mn |